Organization
Institut Paoli-Calmettes
8 clinical trials
Clinical trial
REINFORCED PROPHYLAXIS OF GVH IN ELDERLY PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES RECEIVING HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: USE OF A LOW DOSE OF POST-ALLOGRAFT ANTI-LYMPHOCYTIC SERUMStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
Evaluation of DASATINIB Monotherapy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINEStatus: Not yet recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Phase I/II Study Evaluating M1774, an ATR Inhibitor, in Combination With Fulvestrant in Hormone Receptor-positive and HER2-negative, Advanced Breast Cancers, Resistant to CDK4/6 Inhibitor Plus Aromatase Inhibitor-based Endocrine TreatmentStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Clinical trial
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and RadiotherapyStatus: Active (not recruiting), Estimated PCD: 2021-03-29
Clinical trial
Trans-RosaLEE Study: a Biomarker-directed, Translational Study of High-throughput Molecular Profiling of HR+/HER2- Metastatic Breast Cancer Treated With Endocrine Therapy and Ribociclib.Status: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Phase I, First in Human, Open-label Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute LeukemiaStatus: Recruiting, Estimated PCD: 2023-12-27